Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords

被引:55
作者
Johnson, Alison J. [1 ]
Chu, Chin-Fun [2 ]
Milligan, Gregg N. [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1128/JVI.01159-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In primary infection, CD8(+) T cells are important for clearance of infectious herpes simplex virus (HSV) from sensory ganglia. In this study, evidence of CD8(+) T-cell-mediated clearance of infectious HSV type 1 (HSV-1) from neural tissues was also detected. In immunocompetent mice, HSV-specific CD8(+) T cells were present in sensory ganglia and spinal cords coincident with HSV-1 clearance from these sites and remained detectable at least 8 months postinfection. Neural CD8(+) T cells isolated at the peak of neural infection secreted gamma interferon, tumor necrosis factor alpha, interleukin-2 (IL-2), or IL-4 after stimulation with HSV antigen. HSV-1 titers in neural tissues were greatly reduced over time in CD8(+) T-cell-deficient and CD8(+) T-cell-depleted mice, suggesting that CD8(+) T cells could mediate clearance of HSV-1 from neural tissue. To examine possible mechanisms by which CD8(+) T cells resolved neural infection, CD8(+) T cells were depleted from perforin-deficient or FasL-defective mice. Clearance of infectious virus from neural tissues was not significantly different in perforin-deficient or FasL-defective mice compared to wild-type mice. Further, in spinal cords and brains after vaginal HSV-1 challenge of chimeric mice expressing both perforin and Fas or neither perforin nor Fas, virus titers were significantly lower than in control mice. Thus, perforin and Fas were not required for clearance of infectious virus from neural tissues. These results suggest that HSV-specific CD8(+) T cells are one component of a long-term immune cell presence in neural tissues following genital HSV-1 infection and play a role in clearance of infectious HSV-1 at neural sites, possibly via a nonlytic mechanism.
引用
收藏
页码:9678 / 9688
页数:11
相关论文
共 69 条
[1]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[2]   Cytotoxic CD4+ T cells in viral hepatitis [J].
Aslan, N. ;
Yurdaydin, C. ;
Wiegand, J. ;
Greten, T. ;
Ciner, A. ;
Meyer, M. F. ;
Heiken, H. ;
Kuhlmann, B. ;
Kaiser, T. ;
Bozkaya, H. ;
Tillmann, H. L. ;
Bozdayi, A. M. ;
Manns, M. P. ;
Wedemeyer, H. .
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (08) :505-514
[3]   Herpes simplex virus type 2 vaccines: New ground for optimism? [J].
Aurelian, L .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (03) :437-445
[4]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[5]   Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity [J].
BenMohamed, L ;
Bertrand, G ;
McNamara, CD ;
Gras-Masse, H ;
Hammer, J ;
Wechsler, SL ;
Nesburn, AB .
JOURNAL OF VIROLOGY, 2003, 77 (17) :9463-9473
[6]   Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine [J].
Bernstein, DI ;
Aoki, FY ;
Tyring, SK ;
Stanberry, LR ;
St Pierre, C ;
Shafran, SD ;
Leroux-Roels, G ;
Van Herck, K ;
Bollaerts, A ;
Dubin, G .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1271-1281
[7]   Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system [J].
Burdeinick-Kerr, Rebeca ;
Wind, Jennifer ;
Griffin, Diane E. .
JOURNAL OF VIROLOGY, 2007, 81 (11) :5628-5636
[8]   GAMMA-INTERFERON EXPRESSION DURING ACUTE AND LATENT NERVOUS-SYSTEM INFECTION BY HERPES-SIMPLEX VIRUS TYPE-1 [J].
CANTIN, EM ;
HINTON, DR ;
CHEN, J ;
OPENSHAW, H .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4898-4905
[9]  
COREY L, 2000, PRINCIPLES PRACTICE, P1762
[10]   Why do we lack an effective vaccine against herpes simplex virus infections? [J].
Deshpande, SP ;
Kumaraguru, U ;
Rouse, BT .
MICROBES AND INFECTION, 2000, 2 (08) :973-978